Skip to main content

Table 1 Characteristics of study participants by administrative region, Ethiopian Malaria Indicator Survey-2015 (EMIS-2015)

From: Multiplex serology demonstrate cumulative prevalence and spatial distribution of malaria in Ethiopia

 

Tigray

Afar

Amhara

Oromia

Somali

Benishangul-Gumuz

Southern Nations and Nationalities Peoples’

Gambela

Harari

Diredawa

National

Gender % (95% CI)

n = 8743

 Male

46.5 (44.1–48.9)

47.6 (42.9–52.3)

50.9 (47.4–54.3)

48.2 (45.6–50.9)

45.1 (40.8–49.4)

45.3 (40.8–49.9)

46.4 (44.3–48.5)

41.4 (37.4–45.5)

47.4 (3.0–65.4)

40.5 (33.1–48.4)

47.7 (46.3–49.2)

 Female

53.3 (51.1–55.9)

52.4 (47.7–57.1)

49.1 (45.7–52.6)

51.8 (49.1–54.4)

54.9 (50.6–59.2)

54.7 (50.1–59.2)

53.6 (51.5–55.7)

58.6 (54.5–62.6)

52.6 (34.6–70.0)

59.5 (51.6–66.9)

52.3 (50.8–53.7)

Age group (years)% (95% CI)

 0–5

43.8 (39.6–48.0)

66.6 (63.7–69.3)

40.8 (37.1–44.7)

44.6 (41.5–47.9)

61.7 (58.8–64.6)

49.5 (41.5–57.5)

45.4 (43.2–47.7)

54.8 (50.8–58.8)

25.5 (12.9–44.2)

46.0 (35.3–57.1)

44.8 (43.0–46.5)

 5–15

17.7 (15.2–20.4)

12.8 (9.2–17.5)

20.5 (18.0–23.3)

18.8 (15.8–22.3)

14.6 (11.7–18.1)

16.0 (12.9–19.6)

20.8 (18.9–22.9)

18.9 (16.6–21.5)

3.5 (1.0–11.6)

10.2 (6.6–15.4)

19.4 (17.8–21.1)

 15–25

13.3 (11.3–15.6)

6.1 (3.9–9.4)

12.6 (9.5–16.6)

11.6 (10.0–13.4)

5.2 (3.6–7.5)

11.5 (7.8–16.6)

11.4 (9.7–13.4)

10.7 (8.3–13.8)

22.1 (17.4–27.5)

14.0 (10.9–17.9)

11.7 (10.7–12.8)

 25–50

17.1 (14.9–19.4)

14.1 (12.1–16.4)

19.2 (16.2–22.6)

19.7 (17.5–22.1)

14.6 (13.0–16.4)

14.5 (10.7–19.3)

17.1 (15.6–18.6)

12.3 (1.1–15.0)

36.8 (29.3–45.0)

21.7 (15.9–28.9)

18.5 (17.3–19.8)

 50+

8.2 (6.6–10.1)

0.5 (0.1–1.5)

6.9 (5.1–9.1)

5.2 (3.9–7.0)

3.8 (2.7–5.3)

8.6 (5.3–13.5)

5.2 (4.1–6.6)

3.2 (2.3–4.5)

12.1 (7.4–19.2)

8.1 (4.5–14.2)

5.7 (4.9–6.6)

Elevation (m) % (95% CI)

n = 8740*

 < 1000

5.6 (1.6–17.4)

38.0 (13.7–70.4)

0 (0.0–0.0)

0 (0.0–0.0)

28.6 (12.6–52.7)

8.2 (1.1–52.7)

0 (0.0–0.0)

88.4 (72.1–95.8

0 (0.0–0.0)

0.9 (0.1–6.7)

1.9 (1.2–2.8)

 1000–2000

64.3 (46.8–78.6)

62.0 (29.6–86.3)

53.4 (33.2–72.5)

77.4 (47.3–87.4)

71.4 (47.3–87.4)

91.8 (57.4–98.9)

79.0 (67.3–87.3)

11.6 (4.2–27.9)

100 (100.0–100.0)

99.1 (93.9–99.9)

73.1 (65.6–79.4)

 > 2000

30.2 (16.5–48.5)

0 (0.0–0.0)

46.6 (27.5–66.8)

22.6 (13.1–36.1)

0 (0.0–0.0)

0 (0.0–0.0)

21 (12.7–32.7)

0 (0.0–0.0)

0 (0.0–0.0)

0 (0.0–0.0)

25.0 (18.8–32.5)

Bed net use (last night) % (95% CI)

n = 5168**

 Yes

57.6 (50.3–64.5)

80.5 (65.7–89.9)

59.1 (48.1–69.4)

69.6 (59.6–78.1)

75.2 (61.2–85.4)

66.1 (54.3–76.2)

55.7 (49.4–61.8)

84.7 (76.0–90.6)

33.5 (12.8–63.3)

25 (14.3–41.6)

62.1 (57.5–66.6)

 No

42.4 (35.5–49.7)

19.5 (10.1–34.3)

40.9 (30.6–51.9)

30.4 (21.9–40.4)

24.8 (14.6–38.8)

33.9 (23.8–45.7)

44.3 (38.2–50.6)

15.3 (9.4–24.0)

66.5 (36.7–87.2)

74.4 (58.4–85.7)

37.9 (33.4–42.5)

RDT results % (95% CI)

 Pf

0.8 (0.4–1.6)

0 (0.0–0.0)

0.7 (0.2–1.8)

0.2 (0.1–0.6)

0 (0.0–0.0)

6.2 (2.2–16.3)

0.2 (0.1–0.5)

16.8 (11.8–23.2)

0 (0.0–0.0)

0 (0.0–0.0)

0.5 (0.3–0.7)

 Pan

0.7 (0.3–1.3)

0.2 (0.0–1.3)

0 (0.0–0.0)

0.1 (0.0–0.4)

0.1 (0.0–0.8)

0 (0.0–0.0)

0.4 (0.1–1.2)

0.1 (0.0–0.6)

0 (0.0–0.0)

0 (0.0–0.0)

0.2 (0.1–0.4)

 Pf/Pan

0.1 (0.0–0.6)

0 (0.0–0.0)

0.5 (0.1–1.8)

0 (0.0–0.0)

0 (0.0–0.0)

0.4 (0.0–2.6)

0.2 (0.0–0.6)

1.7 (0.9–3.0)

0 (0.0–0.0)

0 (0.0–0.0)

0.1 (0.1–0.3)

 Negative

98.4 (97.4–99.0)

99.8 (98.7–100.0)

98.9 (96.7–99.6)

99.7 (99.3–99.8)

99.9 (99.2–100.0)

93.5 (82.3–97.8)

99.3 (98.3–99.7)

81.5 (74.5–86.9)

100 (100.0–100.0)

100 100.0–100.0)

99.2 (98.8–99.4)

  1. n, number of observations; RDT, rapid diagnostic test; *3 people did not have GPS coordinates; **3613 individuals were without bed net use data; ***RDT test was not done for 4 individuals; 4 RDT tests were invalid and 3 individuals refused RDT testing